These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12735045)

  • 21. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
    Schömig A; Neumann FJ; Kastrati A; Schühlen H; Blasini R; Hadamitzky M; Walter H; Zitzmann-Roth EM; Richardt G; Alt E; Schmitt C; Ulm K
    N Engl J Med; 1996 Apr; 334(17):1084-9. PubMed ID: 8598866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.
    Testa L; Zoccai GB; Porto I; Trotta G; Agostoni P; Andreotti F; Crea F
    Am J Cardiol; 2007 Jun; 99(12):1637-42. PubMed ID: 17560866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):85-7. PubMed ID: 11010750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Platelet-function inhibitors in the secondary prevention of ischemic stroke].
    Busse O; Diener HC; Grond M
    Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S132-4. PubMed ID: 17089258
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
    Minerva Med; 2003 Apr; 94(2):XIII-IV. PubMed ID: 12916522
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery.
    Cardiac Society of Australia and New Zealand
    Heart Lung Circ; 2010 Jan; 19(1):2-10. PubMed ID: 20045378
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 29. Warfarin and aspirin for prevention of IHD.
    Zamorski MA
    J Fam Pract; 1998 May; 46(5):358-9. PubMed ID: 9597990
    [No Abstract]   [Full Text] [Related]  

  • 30. [Does dual antiplatelet therapy always require gastroprotection? Tailored medical therapy should prevail over the generalized prescription of proton pump inhibitors in patients on dual antiplatelet therapy].
    Marcucci R
    G Ital Cardiol (Rome); 2010 Jun; 11(6):481-7; discussion 487. PubMed ID: 20922874
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
    Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
    Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
    Ornato JP
    Health News; 2002 Nov; 8(11):3. PubMed ID: 12523247
    [No Abstract]   [Full Text] [Related]  

  • 35. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
    Otterstad JE; Brosstad F
    Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
    [No Abstract]   [Full Text] [Related]  

  • 36. Medications used to prevent adhesion and clotting.
    Lassiter TF
    Lippincotts Prim Care Pract; 2000; 4(6):619-32; quiz 633-5. PubMed ID: 11933375
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiplatelet agents and randomized trials.
    Diener HC
    Rev Neurol Dis; 2007; 4(4):177-83. PubMed ID: 18195669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin + clopidogrel therapy: how does your care compare to the evidence?
    Simmons BB; Salzman BE
    J Fam Pract; 2008 Jan; 57(1):26-32. PubMed ID: 18171566
    [No Abstract]   [Full Text] [Related]  

  • 40. [Safety of specific cyclo-oxygenase 2 inhibitors].
    Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1478. PubMed ID: 11503323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.